Industry: Drug Manufacturers - Specialty & Generic Quick infos Headquarters: Montreal, Canada Trade prices Volume: Market Cap: 200.71M Prev closed: 2.28 Open: 2.33 High: 2.38 Low: 2.08 52 week low: 1.33 52 week high: 4.2 Dividends: No Dividends Next ER: April 12, 2023 Before Market Opens
Company Profile Theratechnologies was founded in 1993. Theratechnologies scientists discovered EGRIFTA® (tesamorelin for injection) in 1995. For the next 15 years, Theratechnologies continued to develop this innovative treatment for lipodystrophy in people living with HIV. In 2010, Theratechnologies received a marketing authorization for EGRIFTA® from the US Food and Drug Administration.
Earnings History Date EPS / Forecast Revenue / Forecast July 13, 2023 April 12, 2023 -0.11 / -0.052519.91M / 21.66MFebruary 28, 2023 -0.09 / -0.077521.42M / 20.75MBeat! October 13, 2022 -0.08 / -0.0820.81M / 20.67MBeat! July 14, 2022 -0.24 / -0.2419.27M / 20.3Mview more
Historical Data Date Price Open High Low Vol Change ER Jul 14, 2022 2.88 2.75 2.98
2.75
51.38K 9.51% Jul 13, 2022 2.63 2.66 2.77
2.63
15.59K -0.75% Jul 12, 2022 2.65 2.61 2.67
2.59
8.53K 1.15% Jul 11, 2022 2.62 2.67 2.69
2.62
6.08K -3.32% Jul 8, 2022 2.71 2.71 2.75
2.67
9.28K -1.09% Jul 7, 2022 2.74 2.77 2.81
2.61
38.66K -0.36% Jul 6, 2022 2.75 2.83 2.83
2.70
11.10K -1.79% Jul 5, 2022 2.80 2.95 2.95
2.76
8.02K -4.44% Jul 4, 2022 2.93 2.93 2.95
2.93
6.03K 0.34% Jun 30, 2022 2.92 3.01 3.03
2.85
10.99K -4.89% view more
OTCMKTS - OTC Markets Group (Over-the-Counter)
More profiles and info about the company Founded:19 October 1993 Employees:42 News
Theratechnologies GAAP EPS of -$0.11 misses by $0.06, revenue of $19.9M misses by $1.3M seekingalpha.com Apr 12, 2023 7:34 pm Nasdaq notifies Theratechnologies regarding share price noncompliance seekingalpha.com Mar 7, 2023 7:20 pm Theratechnologies reports Q4 earnings miss; initiates FY23 outlook seekingalpha.com Feb 28, 2023 8:35 pm LYG, AXSM and MMAT among pre market gainers seekingalpha.com Oct 13, 2022 8:39 pm Theratechnologies reports Q3 results, FY22 guidance on track seekingalpha.com Oct 13, 2022 7:47 pm Theratechnologies stock rises 9% on positive data from early-stage trial data of cancer therapy seekingalpha.com Jul 14, 2022 11:39 pm
Theratechnologies Announces US$40 Million Bought-Deal Public Offering of Units finance.yahoo.com Jul 29, 2021 7:13 pm
Theratechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Jul 29, 2021 7:30 am
Theratechnologies to Announce Financial Results for Its Second Quarter Fiscal 2021 finance.yahoo.com Jul 29, 2021 7:30 am Theratechnologies slumps 30% as cancer drug trial enrollment paused on efficacy, safety woes seekingalpha.com Dec 2, 2022 10:20 pm Theratechnologies revenue of $19.27M misses by $0.86M, tightens FY2022 revenue outlook seekingalpha.com Jul 14, 2022 7:38 pm Theratechnologies stock gains on securing $100M term loan seekingalpha.com Jul 13, 2022 10:23 pm Theratechnologies begin enrollment in early-stage study of TH1902 in advanced cancers seekingalpha.com May 10, 2022 8:14 pm Theratechnologies reports Q1 results seekingalpha.com Apr 13, 2022 7:37 pm Theratechnologies GAAP EPS of -$0.34 misses by $0.26, revenue of $18.75M misses by $1.73M seekingalpha.com Feb 24, 2022 8:41 pm Theratechnologies net loss widens in Q3 seekingalpha.com Oct 13, 2021 10:47 pm Theratechnologies EPS misses by $0.03, misses on revenue seekingalpha.com Oct 13, 2021 7:09 pm Theratechnologies reports positive results for Trogarzo IV push administration study seekingalpha.com Sep 22, 2021 8:29 pm
Theratechnologies, Inc. to Host Earnings Call finance.yahoo.com Jul 29, 2021 6:30 am
Theratechnologies, Inc. to Host Earnings Call finance.yahoo.com Jul 29, 2021 6:30 am This company doesn't provide a dividend.
Talk about Theratechnologies below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.